Resolian Acquires China-Based Bioanalytical CRO Denali Medpharma
November 1, 2023
Resolian, a global bioanalytical contract research organization headquartered in Malvern, Pennsylvania, has acquired Denali Medpharma, a Chongqing-based bioanalytical CRO. The acquisition expands Resolian's global lab footprint and adds Denali's oligonucleotide, mRNA, and liposomal bioanalysis capabilities to Resolian's service offerings.
- Buyers
- Resolian
- Targets
- Denali Medpharma
- Industry
- Healthcare Services
- Location
- Chongqing, China
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.